Laurentian Bank of Canada reported net income of $32.3 million and diluted earnings per share of $0.69 for the second quarter of 2025, compared with a net loss of $117.5 million and a diluted loss per ...

Dostarlimab with platinum-based chemotherapy for treating primary advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency TA1064 22 May 2025 22 May ...